Adalimumab

How A Doctor Cured His Own Terminal Disease | Dr. David Fajgenbaum

Andrew Huberman

A TNF inhibitor successfully used to treat a Castleman's patient named Al in Vancouver, leading to a two-year remission and publication in the New England Journal of Medicine.